Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | CDC25B | P30305 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Hydroxy-3,4-Dimethoxybenzoic Acid SCHEMBL28127138 | 0.98 | MAPT (0.96) | MAPTTDP1KDM4EALDH1A1MAPK1 | |
| SCHEMBL27713896 | 0.86 | MAPT (0.76) | MAPTTDP1KDM4EALDH1A1MAPK1 | |
| SCHEMBL11026756 | 0.85 | MAPT (0.73) | MAPTTDP1KDM4EALDH1A1MAPK1 | |
| SCHEMBL335038 | 0.85 | MAPT (0.73) | MAPTTDP1KDM4EALDH1A1MAPK1 | |
| SCHEMBL29405531 | 0.85 | MAPT (0.73) | MAPTTDP1KDM4EALDH1A1MAPK1 | |
| SCHEMBL29378830 | 0.84 | MAPT (0.72) | MAPTTDP1KDM4EALDH1A1MAPK1 | |
| SCHEMBL3189109 | 0.84 | MAPT (0.72) | MAPTTDP1KDM4EALDH1A1MAPK1 | |
| SCHEMBL102827 | 0.84 | MAPT (0.72) | MAPTTDP1KDM4EALDH1A1HPGD | |
| SCHEMBL1434290 | 0.83 | MAPT (0.71) | MAPTTDP1KDM4EALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL5061862 | 0.82 | MAPT (0.70) | MAPTTDP1KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119529253-A | Preparation method and application of citronellol diol related polyester | 武汉科技大学 | 2025-02-28 | — | — | CN | claimed |
| US-11198830-B2 | Grease composition | SHELL OIL COMPANY (US) | 2021-12-14 | — | — | US | claimed |
| CN-104345550-A | Colored photosensitive resin composition, color filter, and liquid crystal display device having the same | DONGWOO FINE CHEM CO LTD | 2015-02-11 | — | — | CN | claimed |
| EP-2448913-B1 | CONTINUOUS METHOD FOR ACYLATING AMINO GROUP-CARRYING ORGANIC ACIDS | CLARIANT FINANCE BVI LTD (VG) | 2013-04-24 | — | — | EP | claimed |
| EP-2448904-B1 | CONTINUOUS METHOD FOR PRODUCING ESTERS OF AROMATIC CARBOXYLIC ACIDS | CLARIANT FINANCE BVI LTD (VG) | 2013-04-17 | — | — | EP | claimed |
| US-20120157370-A1 | WASHING PERFORMANCE USING RADICAL TRAPS | HENKEL AG & CO. KGAA (DE) | 2012-06-21 | — | — | US | claimed |
| EP-2448904-A2 | CONTINUOUS METHOD FOR PRODUCING ESTERS OF AROMATIC CARBOXYLIC ACIDS | Clariant Finance (BVI) Limited (VG) | 2012-05-09 | — | — | EP | claimed |
| EP-2448913-A2 | CONTINUOUS METHOD FOR ACYLATING AMINO GROUP-CARRYING ORGANIC ACIDS | Clariant Finance (BVI) Limited (VG) | 2012-05-09 | — | — | EP | claimed |
| US-20120090983-A1 | Continuous Method For Acylating Amino Group-Carrying Organic Acids | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-19 | — | — | US | claimed |
| US-20120088918-A1 | Continuous Method For Producing Esters Of Aromatic Carboxylic Acids | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-12 | — | — | US | claimed |
| WO-2011000464-A2 | CONTINUOUS METHOD FOR PRODUCING ESTERS OF AROMATIC CARBOXYLIC ACIDS | CLARIANT INTERNATIONAL LTD (CH) | 2011-01-06 | — | — | WO | claimed |
| WO-2011000461-A2 | CONTINUOUS METHOD FOR ACYLATING AMINO GROUP-CARRYING ORGANIC ACIDS | CLARIANT INTERNATIONAL LTD (CH) | 2011-01-06 | — | — | WO | claimed |
| WO-2026106929-A1 | DIHYDROQUINAZOLINES USEFUL AS CYTOMEGALOVIRUS ANTIVIRAL AGENTS | ASSEMBLY BIOSCIENCES, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4680706-A1 | BIODEGRADABLE GREASE COMPOSITION | Shell Internationale Research Maatschappij B.V. (NL) | 2026-01-21 | — | — | EP | disclosed |
| WO-2025217420-A1 | PYRIDINONE COMPOUNDS, METHODS AND USES THEREOF | ZENO MANAGEMENT, INC. (US) | 2025-10-16 | — | — | WO | disclosed |
| EP-4626554-A1 | GLUTARIMIDE-CONTAINING KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | Tiger Biotherapeutics Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-0887344-B1 | Quinolines and quinazolines useful in therapy | PFIZER LTD (GB) | 2003-12-03 | — | — | EP | disclosed |
| US-6417194-B1 | TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | PFIZER, INC. | 2002-07-09 | — | — | US | disclosed |
| US-6048864-A | Quinolines and quinazolines useful in therapy | PFIZER INC (US) | 2000-04-11 | — | — | US | disclosed |
| EP-0887344-A1 | Quinolines and quinazolines useful in therapy | Pfizer Limited (GB) | 1998-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157370-A1 | WASHING PERFORMANCE USING RADICAL TRAPS | MPO, DNASE1, PLD4 | MAPT 2017/4885TDP1 201/4885KDM4E 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.